US consumer group Change to Win has sued Ferris State University, seeking the release of a government contract between the university and CVS Caremark, a pharmacy benefit management company, among other documents. Change to Win is represented by Margaret Kwoka, an attorney at Public Citizen, a non-profit organization with a history of fighting for government transparency, and by attorney Ted Iorio of the Michigan firm Kalniz, Iorio & Feldstein. The case was brought under the Michigan Freedom of Information Act in Mecosta County Circuit Court.
"CVS Caremark's lack of transparency is driving up prescription drug costs for consumers and health plans alike," said Chris Chafe, executive director of Change to Win. "Michigan law protects the people's right to know, in this case, what CVS Caremark is charging the university for prescription drug benefits, but also what compensation CVS Caremark may be receiving in the form of undisclosed agreements with drug manufacturers and pharmacies at taxpayers' expense," he added.
Change to Win filed the suit after Ferris State University, a public college based in Big Rapids, Michigan, partially denied a request for a copy of the CVS Caremark contract. Public Citizen and Change to Win assert that the redacted information, such as prices, should also be disclosed. Change to Win is engaged in an effort to increase the public accountability and transparency of drug middlemen, such as CVS Caremark, to allow for public scrutiny of drug benefits and drug pricing practices.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze